Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 51 Records) |
| Query Trace: Efficiency and Egfr[original query] |
|---|
| Enhanced Specificity of BRAF V600E Genotyping Using Wild-Type Blocker Coupled with Internal Competitive Reference in a Single Tube. Clinical laboratory 2017 Oct 63 (10): 1731-1740. Peng Jia, Wei Kun, Yu Shu, Yang Xiang, Zhao Xiang, Liu Yu, Zhu Xiao-Yan, Zhao Na, Huang Qing, Fu Wei-Li |
| Rs4759314 polymorphism located in HOTAIR is associated with the risk of congenital heart disease by alternating downstream signaling via reducing its expression. Journal of cellular biochemistry 2018 Jun . Li Yunyun, Zhao Wenrong, Shi Ri, Jia Jun, Li Xiaona, Cheng Jingx |
| Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants. Kidney international 2018 06 93 (6): 1409-1416. Nadkarni Girish N, Chauhan Kinsuk, Verghese Divya A, Parikh Chirag R, Do Ron, Horowitz Carol R, Bottinger Erwin P, Coca Steven |
| Prognostic role of circulating tumor cells in patients with EGFR-mutated or ALK-rearranged non-small cell lung cancer. Thoracic cancer 2018 3 9 (5): 640-645. Tong Bing, Xu Yan, Zhao Jing, Chen Minjiang, Zhong Wei, Xing Jia, Wang Mengzh |
| Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China. Scientific reports 2018 Oct 8 (1): 15426. Zhou Yongchun, Ma Yuhui, Shi Hutao, Du Yaxi, Huang Yunch |
| External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants. Pathology oncology research : POR 2019 9 26 (3): 1595-1603. Chai Sze Yee, Peng Rongxue, Zhang Rui, Zhou Li, Pillay Nalishia, Tay Kwang Hong, Badrick Tony, Li Jinming, Horan Martin |
| Comprehensive analysis of EGFR T790M detection by ddPCR and ARMS-PCR and the effect of mutant abundance on the efficacy of osimertinib in NSCLC patients. Journal of thoracic disease 2019 Jul 11 (7): 3004-3014. Li Yue, Xu Yuxia, Wu Xiaoyan, He Caiyun, Liu Qing, Wang Fa |
| Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non-small cell lung cancer patients. Thoracic cancer 2019 May . Kim Insu, Eom Jung Seop, Jo Eun Jung, Mok Ki Uk Jeongha, Lee Kwangha, Uk Kim Ki, Park Hye-Kyung, Lee Min Ki, Kim Mi-Hy |
| [Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2019 5 22 (5): 299-305. Shi Yunshu, Li Panhua, Li Banban, Zhang Fengming, Huang Siyuan, Shen Shujing, Li Xing |
| TP53, EGFR and PIK3CA gene variations observed as prominent biomarkers in breast and lung cancer by plasma cell-free DNA genomic testing. Journal of biotechnology 2019 5 300 87-93. Savli Hakan, Sertdemir Nilüfer, Aydin Duygu, Dursun Bilge, Kurtas Omer, Reka Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Uygun Kaz?m, Ozden Ercan, Isik Ulas, Cabuk Devrim, Demir Gulhan, Guzdolu Eda, Gokbayrak Merve, Aksu Maksut Gorkem, Canturk Nuh Zafer, Cine Na |
| DACT2 modulated by TFAP2A-mediated allelic transcription promotes EGFR-TKIs efficiency in advanced lung adenocarcinoma. Biochemical pharmacology 2019 Dec 113772. Zhang Nasha, Li Yankang, Xie Mengyu, Song Yemei, Liu Jiandong, Lei Tianshui, Shen Yue, Yu Jinming, Yang Mi |
| The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial. Translational lung cancer research 2019 11 8 (5): 575-583. Wang Lili, He Zhen, Yang Sen, Tang Hong, Wu Yufeng, Li Shaomei, Han Baohui, Li Kai, Zhang Li, Shi Jianhua, Wang Zhehai, Cheng Ying, He Jianxing, Shi Yuankai, Chen Weiqiang, Luo Yi, Wu Lin, Wang Xiuwen, Nan Kejun, Jin Faguang, Dong Jian, Li Baolan, Sun Yan, Wang Qimi |
| Epidermal growth factor receptor mutations in lung adenocarcinoma: associations between dual-energy spectral CT measurements and histologic results. Journal of cancer research and clinical oncology 2020 9 147 (4): 1169-1178. Zhang Guojin, Cao Yuntai, Zhang Jing, Zhao Zhiyong, Zhang Wenjuan, Zhou Junl |
| Oncogene HSPH1 modulated by the rs2280059 genetic variant diminishes EGFR-TKIs efficiency in advanced lung adenocarcinoma. Carcinogenesis 2020 Aug . Li Yankang, Zhang Nasha, Zhang Li, Song Yemei, Liu Jie, Yu Jinming, Yang Mi |
| Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients. Oncology letters 2020 4 19 (5): 3495-3505. Ruan Xingya, Sun Yonghua, Wang Wei, Ye Jianwei, Zhang Daoyun, Gong Ziying, Yang Mingx |
| Does metformin improve the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor treatment for patients with advanced non-small-cell lung cancer? Interactive cardiovascular and thoracic surgery 2020 11 32 (1): 73-76. Lin Zhangyu, Li Guangchen, Xu Xinyu, Mei Jiando |
| Differential effects of cisplatin on cybrid cells with varying mitochondrial DNA haplogroups. PeerJ 2020 10 8 e9908. Abedi Sina, Yung Gregory, Atilano Shari R, Thaker Kunal, Chang Steven, Chwa Marilyn, Schneider Kevin, Udar Nitin, Bota Daniela, Kenney M Cristi |
| Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy. Targeted oncology 2020 1 15 (1): 101-113. Olbryt Magdalena, Pig?owski Wojciech, Rajczykowski Marcin, Pfeifer Aleksandra, Student Sebastian, Fiszer-Kierzkowska An |
| Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer. Radiology 2021 10 302 (1): 200-211. Zhong Yifan, She Yunlang, Deng Jiajun, Chen Shouyu, Wang Tingting, Yang Minglei, Ma Minjie, Song Yongxiang, Qi Haoyu, Wang Yin, Shi Jingyun, Wu Chunyan, Xie Dong, Chen Chang, |
| Development and validation of a multivariable predictive model for EGFR gene mutation status in patients with lung adenocarcinoma. Neoplasma 2021 Oct . Shi Yiping, Zha Qiongfang, Ye Qing, Xue Shan, Wu Huawei, Tang Daoqiang, Qin Hui, Zou Ji |
| EGFR tyrosine kinase inhibitors alone or in combination with chemotherapy for non-small-cell lung cancer with EGFR mutations: A meta-analysis of randomized controlled trials. Journal of cancer research and therapeutics 2021 Jul 17 (3): 664-670. Zhu Cui-Min, Lian Xiang-Yao, Zhang Hong-Yan, Bai Lu, Yun Wen-Jing, Zhao Ru-Han, Li Qing-Sh |
| Validation of a highly sensitive Sanger sequencing in detecting EGFR mutations from circulating tumor DNA in patients with lung cancers. Clinica chimica acta; international journal of clinical chemistry 2022 9 536 98-103. Jiang Huiqin, Chen Xinning, Huang Fei, Xu Xue, Dong Bohao, Luo Junfeng, Yang Hongxing, Zhang Chunyan, Pan Baishen, Wang Beili, Guo W |
| Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial. JAMA oncology 2022 7 8 (9): 1328-1332. Xu Jiachen, Liu Zheng, Bai Hua, Dong Guilan, Zhong Jia, Wan Rui, Zang Aiming, Li Xiaoling, Li Qingshan, Guo Jun, Du Nan, Zhong Diansheng, Huang Yan, Lv Qun, Zhang Jinghua, Zhao Yue, Gao Liming, Li Lin, Zhang Chunyi, Zhao Jun, Li Baolan, Liu Zhe, Yang Zhenlin, Ji Dong, Wang Tao, Duan Jianchun, Wang Zhijie, Wang J |
| The RNA editing enzyme ADAR modulated by the rs1127317 genetic variant diminishes EGFR-TKIs efficiency in advanced lung adenocarcinoma. Life sciences 2022 2 296 120408. Hua Hui, Zeng Jiajia, Xing Haixin, He Yuxin, Han Linyu, Zhang Nasha, Yang Mi |
| A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer. Medicine 2022 12 101 (47): e31894. Cui Ran, Wei Chun, Li Xianyi, Jiang |
| Predictive value of multiple metabolic and heterogeneity parameters of F-FDG PET/CT for EGFR mutations in non-small cell lung cancer. Annals of nuclear medicine 2022 Jan . Shi Aiqi, Wang Jianling, Wang Yuzhu, Guo Guorong, Fan Chouchou, Liu Jiangy |
| IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. Frontiers in immunology 2023 11 14 1282734. Qisheng Luo, Junhong Zhuang, Dandan Zheng, Changfeng Miao, Hongcheng Luo, Jun Peng, Chuanhua Zheng, Chengjian Qin, Chuanliu Lan, Meiqin Chen, Ying Xia, Deyou Huang, Zigui Ch |
| Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion. Current oncology (Toronto, Ont.) 2023 11 30 (11): 9929-9939. Yue Zheng, Yang Fu, Yueyun Chen, Qing Li, Ting Liu, Zhenyu Di |
| Clinical, Imaging, and Pathological-Molecular Characteristics Associated with Stage IA Invasive Lung Adenocarcinoma Recurrence After Sub-lobar Resection. Academic radiology 2024 7 . Xin Fan, Chen Liang, Xueqin Ma, Qi |
| The predictive value of serum tumor markers for EGFR mutation in non-small cell lung cancer patients with non-stage IA. Heliyon 2024 5 10 (9): e29605. Wenxing Du, Tong Qiu, Hanqun Liu, Ao Liu, Zhe Wu, Xiao Sun, Yi Qin, Wenhao Su, Zhangfeng Huang, Tianxiang Yun, Wenjie Ji |
- Page last reviewed:Feb 1, 2024
- Content source: